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OBJECTIVE: Depression is a recurrent and chronic disorder
among elderly patients with chronic medical conditions. The
objective of this study was to determine predictors of depressive
symptomatology in elderly population with type 2 diabetes mel-
litus. METHODS: A cross sectional study was conducted by
administering a health status assessment questionnaire to nearly
1000 older adults (≥65 years) with type 2 diabetes mellitus in
the southern United States (Response rate: approximately 85%).
The instrument collected information related to demographics,
general health status, clinical conditions, medication use,
lifestyle, functional status and prior health care service utiliza-
tion. The Short Form Center for Epidemiologic Studies Depres-
sion scale was used to assess depressive symptoms. Partial
correlations and multivariate logistic regression analyses were
conducted using the linked survey and health care claims data.
RESULTS: Of the 885 respondents, about 17% had depressive
symptoms. Most participants (60%) were women with mean age
of 71 (±8.7) years. Almost 96.7% of patients were using 1 or
more antidiabetic medications. Overall, higher general health
status was associated with lower level of depression (OR: 0.38,
95% CI: 0.23–0.61). However, impairments in daily activities
were associated with higher depression (OR: 1.25, 95% CI:
1.08–1.44). When categorized by type of antidiabetic therapy
based on actual prescription claims data, we found that increased
number of prescriptions was associated with higher risk of
depressive symptoms (OR: 2.39, 95% CI: 1.05–5.44) in patients
on insulin compared to those other therapies. In addition, higher
risk of depressive symptoms was associated with self reported
number of falls (OR: 2.17, 95% CI: 1.1–4.28), and emergency
room visits (OR: 1.57, 95% CI: 1.11–2.22) in the previous year
in patients on sulphonyl ureas. CONCLUSION: General health
status and impairments in daily activities were predictors of
depressive symptomatology in elderly with diabetes. Determi-
nants of depression varied according to pharmacotherapeutic
class of antidiabetic medications.
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OBJECTIVE: To measure quality of life of people with type 2
diabetes (T2D) and those with varying risk levels for T2D in the
baseline survey of the Study to Help Improve Early evaluation
and management of risk factors Leading to Diabetes (SHIELD),
a 5-year longitudinal study. METHODS: A 64-item baseline
survey was sent to 22,001 people who self-reported T2D or
varying numbers of risk factors (RF) associated with T2D diag-
nosis: abdominal obesity, high body mass index, hypertension,
dyslipidemia, and history of cardiovascular events. Among other
items, respondents completed the Short Form-12 version 2 (SF-
12) and EuroQol—Five Dimension scale (EQ-5D). Norm-based
scoring (population mean = 50) was used for the SF-12. For both
scales, higher scores indicate better quality of life. RESULTS:
Surveys were returned by 17,640 individuals (80% response
rate). Mean SF-12 physical component summary scores for
respondents with T2D and those with 3–5 RF were similar (39.5
and 41.7, respectively) and substantially lower than for those
with 0–2 RF (50.6). Mean ratings of overall health on the EQ-
5D 0–100 visual analog scale were signiﬁcantly higher for
respondents with 0–2 RF (79.6) than for those with 3–5 RF
(70.4) or T2D (66.8). Examination of individual domains of the
SF-12 revealed remarkably similar scores between the T2D and
3–5 RF groups on all domains, and signiﬁcant decrements com-
pared with the 0–2 RF group for all domains except mental
health. These two groups also exhibited similar proﬁles over EQ-
5D dimensions, with the largest impacts on mobility, usual activ-
ity, and pain/discomfort. CONCLUSIONS: Findings from
SHIELD reveal remarkably similar ratings of health-related
quality of life in people with T2D and those at increased risk for
diabetes, with considerably worse quality of life than those at
lower levels of risk for diabetes.
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OBJECTIVES: To identify stress and coping strategies associated
with physical and mental HRQoL in primary care patients with
type 2 diabetes mellitus (T2DM). METHODS: Primary care
patients with T2DM from three primary care clinics completed
questionnaires during their regularly scheduled clinic appoint-
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